![John Butler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Butler
Chief Executive Officer at
AKEBIA THERAPEUTICS, INC.
Net worth: 2 M $ as of 31/05/2026
Profile
John P.
Butler is President, Chief Executive Officer & Director at Akebia Therapeutics, Inc. since 2024.
He is Director at Wavebreak Therapeutics Ltd. since 2023.
He is a Member of the Health Section Governing Board at Biotechnology Innovation Organization since 2024.
Former roles include Chief Executive Officer at Inspiration Biopharmaceuticals, Inc. in 2011; Chairman at Keryx Biopharmaceuticals, Inc. from 2016 to 2017; Chairman at American Kidney Fund, Inc. from 2013 to 2015; Chairman at Kidney Care Partners from 2020 to 2024; Independent Director at Harmony Biosciences Management, Inc. from 2018 to 2023; Independent Director at Relypsa, Inc. from 2013 to 2016; Product Manager at Amgen, Inc. from 1995 to 1997; SVP & President-Cardiometabolic & Renal at Genzyme Corp.
from 2009 to 2011; and Head of Sales & Marketing at Hoffmann-La Roche, Inc. Education includes undergraduate studies at Manhattan University and an MBA from Baruch College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 22,06,149 ( 0.82% ) | 2 M $ | 31/05/2026 |
John Butler active positions
| Companies | Position | Start |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Chief Executive Officer | 16/09/2013 |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Director/Board Member | 01/01/2023 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | 01/01/2024 |
Former positions of John Butler
| Companies | Position | End |
|---|---|---|
Kidney Care Partners
 Kidney Care Partners Medical/Nursing ServicesHealth Services Operates as nephrologists | Chairman | 01/01/2024 |
| ZYNERBA PHARMACEUTICALS, INC. | Director/Board Member | 10/10/2023 |
| KERYX BIOPHARMACEUTICALS | Chairman | 01/01/2017 |
| RELYPSA INC | Director/Board Member | 01/09/2016 |
American Kidney Fund, Inc.
 American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services Provides treatment & financial assistance to kidney patients | Chairman | 01/01/2015 |
Training of John Butler
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
82
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Zynerba Pharmaceuticals, Inc.
 Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Manhattan College
 Manhattan College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baruch College
 Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Kidney Care Partners
Kidney Care Partners Medical/Nursing ServicesHealth Services Operates as nephrologists | Health Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
American Kidney Fund, Inc.
American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services Provides treatment & financial assistance to kidney patients | Health Services |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Health Technology |
- Stock Market
- Insiders
- John Butler
Choose MarketScreener 
